04.03.2021: The Hub is proud to put forward to the G7 & G20, key emerging insights from its forthcoming studies that it was tasked to undertake by its board of members and G20 Leaders. The results of our initial studies reiterate the challenges that remain in the post-market space and propose concrete steps forward in accelerating antimicrobial development and access for building a more secure future ecosystem.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.